Article
Drug Access: GSK Gives Consent to Canadian Drug Company To Manufacture Generic Antiretroviral for Rwanda
GlaxoSmithKline on Wednesday announced that it has given consent to Toronto-based drug company Apotex to use two of its patented antiretroviral drugs...to manufacture Apo-triAvir -- a fixed-dose combination of the two drugs and the antiretroviral nevirapine -- for Rwanda... Boehringer Ingelheim agreed last month to allow Apotex to use its antiretroviral nevirapine in the combination therapy...